[1]黄绮娟,陈劲新,黄小良.丁苯酞联合依达拉奉治疗非致残性脑梗死的效果及对患者神经功能的影响[J].医学信息,2021,34(08):144-146.[doi:10.3969/j.issn.1006-1959.2021.08.038]
　HUANG Qi-juan,CHEN Jin-xin,HUANG Xiao-liang.The Effect of Butylphthalide Combined with Edaravone in the Treatment of Non-disabling Cerebral Infarction and Its Influence on Patients’ Neurological Function[J].Medical Information,2021,34(08):144-146.[doi:10.3969/j.issn.1006-1959.2021.08.038]
点击复制

丁苯酞联合依达拉奉治疗非致残性脑梗死的效果及对患者神经功能的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年08期
页码:
144-146
栏目:
药物与临床
出版日期:
2021-04-15

文章信息/Info

Title:
The Effect of Butylphthalide Combined with Edaravone in the Treatment of Non-disabling Cerebral Infarction and Its Influence on Patients’ Neurological Function
文章编号:
1006-1959（2021）08-0144-03
作者:
黄绮娟; 陈劲新; 黄小良
（台山市人民医院神经内科，广东 台山 529200）
Author(s):
HUANG Qi-juan; CHEN Jin-xin; HUANG Xiao-liang
(Department of Neurology,Taishan People’s Hospital,Taishan 529200,Guangdong,China)
关键词:
丁苯酞; 依达拉奉; 非致残性脑梗死; 神经功能
Keywords:
Butylphthalide; Edaravone; Non-disabling cerebral infarction; Neural function
分类号:
R743.3
DOI:
10.3969/j.issn.1006-1959.2021.08.038
文献标志码:
A
摘要:
目的 分析丁苯酞联合依达拉奉治疗非致残性脑梗死的临床效果，观察其对患者神经功能的影响。方法 选择2018年1月~2019年12内我院50例非致残性脑梗死患者作为研究对象，按随机原则将其分为观察组与对照组，各25例，对照组接受依达拉奉治疗，观察组采用丁苯酞联合依达拉奉治疗，比较两组血清Hcy水平、神经功能评分、治疗效果及C反应蛋白水平差异。结果 两组血清Hcy水平均较治疗前改善，且观察组优于对照组，差异有统计学意义（P＜0.05）；治疗后7、14 d，两组NIHSS评分均较治疗前降低，且观察组低于对照组，差异有统计学意义（P＜0.05）；治疗后7、14 d，两组C反应蛋白水平均较治疗前升高，且观察组高于对照组，差异有统计学意义（P＜0.05）；观察组治疗总有效率高于对照组（100.00% vs 88.00%），差异有统计学意义（P＜0.05）。结论 丁苯酞联合依达拉奉治疗非致残性脑梗死疗效确切，有助于改善患者的神经功能和炎性反应，对促进患者康复有重要作用。
Abstract:
Objective To analyze the clinical effect of butylphthalide combined with edaravone in the treatment of non-disabling cerebral infarction, and observe its effect on patients’ neurological function.Methods From January 2018 to December 2019, 50 patients with non-disabling cerebral infarction in our hospital were selected as the research objects. According to the principle of randomization, they were divided into observation group and control group, each with 25 cases.The control group received edaravone treatment, and the observation group was treated with butylphthalide combined with edaravone. The differences in serum Hcy levels, neurological function scores, therapeutic effects and C-reactive protein levels were compared between the two groups.Results The levels of serum Hcy in the two groups were improved compared to before treatment, and the observation group was better than the control group, the difference was statistically significant (P<0.05);At 7 and 14 d after treatment, the NIHSS scores of the two groups were lower than before treatment, and the observation group was lower than the control group, the difference was statistically significant (P<0.05);At 7 and 14 d after treatment, the levels of C-reactive protein in the two groups were higher than before treatment, and the observation group was higher than the control group, the difference was statistically significant (P<0.05);The total effective rate of treatment in the observation group was higher than that in the control group (100.00% vs 88.00%),the difference was statistically significant (P<0.05).Conclusion The combination of butylphthalide and edaravone is effective in treating non-disabling cerebral infarction, which can help improve the patient’s neurological function and inflammatory response, and play an important role in promoting the recovery of patients.

参考文献/References:

[1]朱新华,刘周婷,肖兴,等.丁苯酞注射液与依达拉奉联合治疗对急性脑梗死患者血清Hcy、UA及神经功能的影响[J].解放军预防医学杂志,2019,5(8):15-16. [2]中国卒中学会指南编写组.高危非致残性缺血性脑血管事件诊疗指南[J].中国卒中杂志,2016,11(6):481-491. [3]郝锋利,徐巧绒,赵志茹.丁苯酞联合依达拉奉治疗急性脑梗死的效果及对患者神经功能的影响[J].临床医学研究与实践,2019,4(22):27-29. [4]Liu Q,Wang B,Liu Y,et al.Frequency-specific Effective Connectivity in Subjects with Cerebral Infarction as Revealed by NIRS Method[J].Neuroscience,2018,1(5):5. [5]申宝芹.依达拉奉联合丁苯酞对急性脑梗死患者神经功能及TXA2、PGI2水平的影响[J].国际医药卫生导报,2018,24(12):1839-1841. [6]Araki Y,Furuichi M,Nokura H,et al.Influence of Pre-existing Cognitive Impairment on Rehabilitation Outcomes in Patients with Cerebral Infarction[J].Brain and Nerve,2018,70(6):651-660. [7]苏晓丽.循证护理联合丁苯酞及依达拉奉对急性脑梗死患者炎性因子和氧化应激的影响[J].河北医药,2019,6(12):10-12. [8]卫家芬,徐雪明,邓小玲,等.龙生蛭胶囊联合丁苯酞治疗脑梗死的临床疗效及对血清炎症因子的影响[J].山西医药杂志,2019,3(16):12-15. [9]尹楠,陈华,段瑞生.法舒地尔联合丁苯酞软胶囊治疗急性脑梗死的效果及对血清MMP-2、MMP-9水平的影响[J].河北医科大学学报,2018,39(12):1376-1379. [10]Dai ZY,Chen F,Yao LZ,et al.The combined application of magnetic resonance DTI and 3D-pcASL in differential diagnosis of hyper-acute and acute ischemic cerebral infarction[J].National Medical Journal of China,2018,98(17):1327. [11]曹国军,张行丰,郑科达.丁苯酞联合阿替普酶对急性缺血性脑卒中患者神经保护作用及血清炎性标志物的影响[J].浙江医学,2018,7(11):5-8. [12]李俊,庞洪波,胡勇,等.丁苯酞氯化钠注射液联合依达拉奉对急性脑梗死患者神经功能及日常生活能力的影响[J].贵州医科大学学报,2018,214(7):74-77. [13]王晓宇,朱彩花,楼滟.血栓通联合丁苯酞对老年急性脑梗死血清中Fibulin-5、BDNF及S100B的影响[J].中华中医药学刊,2018,4(1):6. [14]Choi JI,Ha SK,Lim DJ,et al.S100?,Matrix Metalloproteinase-9,D-dimer,and Heat Shock Protein 70 Are Serologic Biomarkers of Acute Cerebral Infarction in a Mouse Model of Transient MCA Occlusion[J].Journal of Korean Neurosurgical Society,2018,61(5):15-18. [15]吴志元,黄振华,钟守磊,等.丁苯酞联合依达拉奉治疗急性脑梗死合并脑微出血的疗效观察[J].广东医科大学学报,2019,37(2):190-194.

相似文献/References:

[1]刘 阳,李新萍,吴细建.依达拉奉联合脑苷肌肽治疗重症颅脑损伤患者的疗效[J].医学信息,2019,32(22):103.[doi:10.3969/j.issn.1006-1959.2019.22.032]
　LIU Yang,LI Xin-ping,WU Xi-jian.Edaravone Combined with Cerebroside Carnosine in the Treatment of Patients with Severe Head Injury[J].Medical Information,2019,32(08):103.[doi:10.3969/j.issn.1006-1959.2019.22.032]
[2]曹金强,毛士明,汪万国.奥扎格雷联合依达拉奉治疗急性脑梗死的效果[J].医学信息,2020,33(01):140.[doi:10.3969/j.issn.1006-1959.2020.01.044]
　CAO Jin-qiang,MAO Shi-ming,WANG Wan-guo.Effect of Ozagrel Combined with Edaravone on Acute Cerebral Infarction[J].Medical Information,2020,33(08):140.[doi:10.3969/j.issn.1006-1959.2020.01.044]
[3]谢海辉,张 曙,黎建文,等.依达拉奉对老年髋关节置换术患者血清CXCL13水平及PND的影响[J].医学信息,2020,33(05):67.[doi:10.3969/j.issn.1006-1959.2020.05.020]
　XIE Hai-hui,ZHANG Shu,LI Jian-wen,et al.Effect of Edaravone on Serum CXCL13 Level and PND in Elderly Patients with Hip Replacement[J].Medical Information,2020,33(08):67.[doi:10.3969/j.issn.1006-1959.2020.05.020]
[4]李 丹.丁苯酞联合银杏达莫治疗急性脑梗死的疗效[J].医学信息,2020,33(05):161.[doi:10.3969/j.issn.1006-1959.2020.05.053]
　LI Dan.Efficacy of Butylphthalide Combined with Ginkgo Leaf Extract and Dipyridamole in the Treatment of Acute Cerebral Infarction[J].Medical Information,2020,33(08):161.[doi:10.3969/j.issn.1006-1959.2020.05.053]
[5]赵林珊,刘 兴,耿 瑜.丁苯酞注射液治疗急性前循环脑梗死的效果[J].医学信息,2020,33(13):113.[doi:10.3969/j.issn.1006-1959.2020.13.032]
　ZHAO Lin-shan,LIU Xing,GENG Yu.Effect of Butylphthalide Injection on Acute Anterior Circulation Cerebral Infarction[J].Medical Information,2020,33(08):113.[doi:10.3969/j.issn.1006-1959.2020.13.032]
[6]管海兵,葛 胜,沈 斌.阿托伐他汀钙联合依达拉奉对急性脑梗死患者hs-CRP和同型半胱氨酸水平的影响[J].医学信息,2021,34(19):110.[doi:10.3969/j.issn.1006-1959.2021.19.028]
　GUAN Hai-bing,GE Sheng,SHEN Bin.The Effect of Atorvastatin Calcium Combined with Edaravone on hs-CRP andHomocysteine Levels in Patients with Acute Cerebral Infarction[J].Medical Information,2021,34(08):110.[doi:10.3969/j.issn.1006-1959.2021.19.028]
[7]贾红芳,董林森,李文芳.尤瑞克林联合丁苯酞治疗急性缺血性脑卒中的效果及对神经功能的影响[J].医学信息,2021,34(22):139.[doi:10.3969/j.issn.1006-1959.2021.22.043]
　JIA Hong-fang,DONG Lin-sen,LI Wen-fang.Effect of Urinary Kallidinogenase Combined with Butylphthalide on Acute Ischemic Stroke and its Effect on Neurological Function[J].Medical Information,2021,34(08):139.[doi:10.3969/j.issn.1006-1959.2021.22.043]
[8]荣丽红,张恒春.血栓通联合依达拉奉治疗急性脑梗塞患者的效果[J].医学信息,2021,34(22):148.[doi:10.3969/j.issn.1006-1959.2021.22.046]
　RONG Li-hong,ZHANG Heng-chun.Effect of Xueshuantong Combined with Edaravone on Patients with Acute Cerebral Infarction[J].Medical Information,2021,34(08):148.[doi:10.3969/j.issn.1006-1959.2021.22.046]
[9]娄永忠,王 涛,郭筱菲,等.丁苯酞对缺血性脑卒中患者神经功能缺损程度影响的临床研究[J].医学信息,2022,35(04):115.[doi:10.3969/j.issn.1006-1959.2022.04.028]
　LOU Yong-zhong,WANG Tao,GUO Xiao-fei,et al.Clinical Study on the Effect of Butylphthalide on Neurological Deficits in Patients with Ischemic Stroke[J].Medical Information,2022,35(08):115.[doi:10.3969/j.issn.1006-1959.2022.04.028]
[10]褚春沐.丁苯酞序贯治疗对急性进展性脑梗死患者神经功能、炎症因子及Hcy、NSE的影响[J].医学信息,2022,35(17):129.[doi:10.3969/j.issn.1006-1959.2022.17.035]
　CHU Chun-mu.Effect of Butylphthalide Sequential Therapy on Neurological Function, Inflammatory Factors, Hcy and NSE in Patients with Acute Progressive Cerebral Infarction[J].Medical Information,2022,35(08):129.[doi:10.3969/j.issn.1006-1959.2022.17.035]

更新日期/Last Update: 1900-01-01